Panel Discussion: Exploring Modalities & Innovations: Delivering Biologics vs Small Molecules vs Nanoparticles

Time: 4:15 pm
day: Conference Day 1


With a historic prevalence of delivering small molecules via the inhalation route, what are the key differences

and considerations when delivering biologics such as mRNA, DNA, peptides and nanoparticle-mediated delivery compared with small molecules.

Join this panel discussion to understand:

  • Formulation considerations of small molecules vs biologics
  • Specific target engagement: small molecules are not that specific resulting in unwanted side effects
  • Shear force and bioactivity: understanding that macromolecules are more susceptible to shear force and their solid / chemical stability needs to be protects
  • Using nanoparticles for delivery: particle aggregation and immune response